Business

IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial

IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial

Imagion Biosystems Ltd.February 1, 20263

IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial

About this update from Imagion Biosystems Ltd.

Imagion Biosystems Ltd has released a press release. View Attachment

View stock analysis, news, and events for Imagion Biosystems Ltd.

More from Imagion Biosystems Ltd.

Imagion Resumes MagSense® Nanoparticle Manufacturing Capabilities

September 14, 2026

IBX Phase 2 Clinical Trial Update

August 25, 2026

All Imagion Biosystems Ltd. news →